Lataa...
A Tool to Utilize Adverse Effect Profiles to Identify Brain-Active Medications for Repurposing
BACKGROUND: To shorten the time required to bring new treatments to clinics, recent efforts have focused on repurposing existing Food and Drug Administration (FDA)-approved drugs with established safety data for new indications. We hypothesized that adverse effect profiles might aid in prioritizing...
Tallennettuna:
| Julkaisussa: | Int J Neuropsychopharmacol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4360243/ https://ncbi.nlm.nih.gov/pubmed/25673184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyu078 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|